A new genetic test has been developed by a team of researchers from Wake Forest
University School of Medicine and Karim Kader, MD, PhD, associate clinical professor at the UC San Diego
School of Medicine to predict
a man's risk for prostate cancer. Use of the test could reduce the need
for repeat biopsies in men who have had a negative biopsy. Avoiding the need for repeat proceedures could help reduce the potential for infection and possible subsequent hospitalisation.
According to Karim Kader "The genetic test outperformed the PSA test in assessing cancer risk,"going on to say "If results of this blood test were factored into prostate cancer
predictors such as total free PSA, free PSA, number of core samples
taken at biopsy, and family history, we would have a more accurate
picture of a whether or not a man is likely to develop the sometimes
fatal disease."
Read more detail in ScienceDaily:New test may help predict prostate cancer
No comments:
Post a Comment
Please be courteous and add your name rather than 'Anonymous' to your comment, as it may not be published. In the 'Comment as' box above use the drop-down menu and select 'Name/URL'. In the 'Edit profile' pop-up enter your name and press continue. There will be a period of delay before your comment appears on the article until I receive the automatic notification that you have made one and can authorised its publication.
Any comment that includes vulgar language, racist remarks or anything of that nature will either be edited or not published at my discretion.